Guruprakash Subbiahdoss

Dr. Guruprakash Subbiahdoss is a Senior Scientist at the Institute of Colloid and Biointerface Science, Department of Natural Sciences and Sustainable Resources, University of Natural Resources and Life Sciences, Vienna (BOKU). He has been with BOKU since 2018 and is also an Associated faculty member at the Doctoral School "Biomaterials and Biointerfaces" (BioMatInt) since 2021. His research focuses on biofilms, biomaterial-associated infections, surface modifications, and bioremediation.

Dr. Subbiahdoss earned his PhD in Biomedical Engineering from Rijks University Groningen (2006-2010), followed by an MSc in Biomedical Engineering from Aachen University of Applied Sciences, Germany (2002-2005), and a B.Eng. in Mechanical Engineering from Mepco Schlenk Engineering College, India (1997-2001). Prior to joining BOKU, he conducted postdoctoral research at Aarhus University, Denmark (2015-2018) and UMCG, Groningen, The Netherlands (2010-2012), and served as Teaching Faculty at SSN College of Engineering, Chennai, India (2012-2014).

His research interests span biofilms, biomaterials, implant-associated infections, cell-material interactions, biophysics, biomedical engineering, tissue engineering, nanomaterials, microbiology, and surface chemistry. Dr. Subbiahdoss investigates how bacterial biofilms form on surfaces, particularly at interfaces like oil-water boundaries, and develops strategies to prevent biofilm formation on medical implants through surface modifications. His work has significant implications for preventing biomaterial-associated infections and improving medical device safety.

Analysis of Dr. Subbiahdoss's recent publications reveals a strong focus on biofilm formation mechanisms, particularly at interfaces, and the development of novel surface coatings to prevent bacterial adhesion while promoting mammalian cell integration. His research bridges fundamental biophysics with practical applications in medical device development, with particular emphasis on DNA-based polyelectrolyte multilayer coatings, antimicrobial strategies, and the characterization of bacterial behavior at material interfaces. The interdisciplinary nature of his work spans microbiology, materials science, surface chemistry, and biomedical engineering.

Dr. Subbiahdoss has received numerous awards and recognitions including:

• Member of Management Committee for the COST Action CA23152 "Biofilm Regulatory Toolbox" (2024)
• Guest Editor for Colloids and Surfaces B: Bio-interfaces (2023)
• Hochschuljubiläumsfonds der Stadt Wien (2023)
• Member of editorial board for section Biomedical Materials, MDPI Biomedicines (2022)
• Certificate of service as guest editor of special issue "Biofilms at Interfaces" MDPI Biomedicines (2021)
• Lundbeck Foundation grant as Co-PI (2016)
• Certificate of excellence in reviewing award from Elsevier (2013)
• Best poster award at BMSA congress, The Netherlands (2008)

Dr. Subbiahdoss leads and participates in multiple research projects funded by prestigious organizations including the Austrian Science Fund (FWF), City of Vienna, and European Commission. His current projects include "Race for the surface: DNA Multilayer coatings can simultaneously prevent implant infection and support osseointegration" (as Project Leader), "Biofilm on microplastics - a biophysical perspective," and "MICRObial wettability by particle Contact Angle Measurements." He serves as a reviewer for journals including BMC Microbiology, Communications Materials, Scientific Reports, and Frontiers in Microbiology, and has acted as Guest Editor for special issues on biomaterial-associated infections.

Dr. Subbiahdoss is actively involved in the scientific community, presenting his research at international conferences worldwide. His work is conducted within the Institute of Colloid and Biointerface Science at BOKU, collaborating with researchers across disciplines to address challenges in biomaterials and biofilm research. His laboratory investigates the fundamental mechanisms of biofilm formation and develops innovative solutions for preventing biomaterial-associated infections, with potential applications in medical device development and environmental bioremediation.